Biora Therapeutics, Inc. Operating Lease, Payments
Biora Therapeutics, Inc. reported Operating Lease, Payments of $800.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2024-11-14
- Biora Therapeutics, Inc. operating lease, payments for the quarter ending 2024-09-30 was $500.00K, a 400.00% increase year-over-year.
- Biora Therapeutics, Inc. operating lease, payments for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Biora Therapeutics, Inc. operating lease, payments for the quarter ending 2024-03-31 was $300.00K, a 25.00% decline year-over-year.
- Biora Therapeutics, Inc. operating lease, payments for the quarter ending 2023-12-31 was $381.00K, a 6.85% decline year-over-year.
- Biora Therapeutics, Inc. operating lease, payments for fiscal 2023 was $1.28M, a 20.39% decline from fiscal 2022.
- Biora Therapeutics, Inc. operating lease, payments for fiscal 2022 was $1.61M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $500.00K derived: sum of 2 quarters · filed 2024-11-14 | $800.00K 10-Q · filed 2024-11-14 | $1.18M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $300.00K 10-Q · filed 2024-08-12 | $681.00K derived: sum of 3 quarters · filed 2024-08-12 | $781.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-03-31 | $300.00K 10-Q · filed 2024-05-15 | $681.00K derived: sum of 2 quarters · filed 2024-05-15 | $781.00K derived: sum of 3 quarters · filed 2024-11-14 | $1.18M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-12-31 | $381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $481.00K derived: sum of 2 quarters · filed 2024-11-14 | $881.00K derived: sum of 3 quarters · filed 2024-11-14 | $1.28M 10-K · filed 2024-04-01 | |
| 2023-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $500.00K derived: sum of 2 quarters · filed 2024-11-14 | $900.00K 10-Q · filed 2024-11-14 | $1.31M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $800.00K 10-Q · filed 2024-08-12 | $1.21M derived: sum of 3 quarters · filed 2024-08-12 | $1.61M derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $400.00K 10-Q · filed 2024-05-15 | $809.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.21M derived: sum of 3 quarters · filed 2024-05-15 | $1.21M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $809.00K derived: sum of 2 quarters · filed 2024-04-01 | $809.00K derived: sum of 3 quarters · filed 2024-04-01 | $1.61M 10-K · filed 2024-04-01 | $1.60M 10-K · filed 2023-03-30 |
| 2022-09-30 | $400.00K 10-Q · filed 2022-11-14 | $400.00K derived: sum of 2 quarters · filed 2023-08-14 | $1.20M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $400.00K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $400.00K 10-Q · filed 2023-05-15 |